As those of you on the DXB forum know, DXB has been slow cooking for a while now. For me the buy signals were:
1. Very strong OBV.
2. Commencement of the current short term uptrend which in turn followed a retrace to the vicinity of the neckline after the initial breakout from the neckline.
The story is good, and will get better once Dimerix are in a position to introduce a sustained release form of propagermanium. Cutting out the middle of the day dosage should do wonders for patient compliance down the track.
Chartwatch - DXB
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
54.5¢ |
Change
0.005(0.93%) |
Mkt cap ! $296.8M | |||
| Open | High | Low | Value | Volume |
| 54.0¢ | 55.0¢ | 53.0¢ | $205.9K | 382.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3060 | 54.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 55.0¢ | 227904 | 14 |
View Market Depth
| Last trade - 10.28am 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
55.0¢ |
Change
0.005 ( 2.59 %) |
||||
| Open | High | Low | Volume | ||
| 53.0¢ | 55.0¢ | 52.5¢ | 549061 | ||
| Last updated 10.46am 07/06/2024 ? | |||||
| DXB (ASX) Chart |